| Reference : Traitement du cancer colorectal. Aspects pharmaco-économiques |
| Scientific journals : Article | |||
| Human health sciences : Oncology | |||
| http://hdl.handle.net/2268/2317 | |||
| Traitement du cancer colorectal. Aspects pharmaco-économiques | |
| French | |
| [en] Treatment of Colorectal Cancer. Pharmaco-Economic Aspects | |
Jerusalem, Guy [Centre Hospitalier Universitaire de Liège - CHU > > Oncologie médicale >] | |
Bours, Vincent [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Génétique générale et humaine] | |
Fillet, Georges [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale] | |
| May-1998 | |
| Revue Médicale de Liège | |
| 53 | |
| 5 | |
| 276-8 | |
| National | |
| 0370-629X | |
| [en] Cancer patients care is mainly based on scientific studies, but sometimes approaches are empiric. Rapid growth of health care expenses force the physician to take pharmacoeconomic aspects into consideration. New clinical studies have to analyse clinical benefits but also cost-effectiveness. We will review the various aspects of colorectal cancer from primary prevention to post-treatment follow-up. Scientific data are integrated in a pharmacoeconomic analysis. | |
| http://hdl.handle.net/2268/2317 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.